Wall Street analysts think Facebook's cryptocurrency payments project will give the company a big boost.Marketsread more
Facebook's reported move into cryptocurrency could amount to the biggest catalyst for digital assets in their decade-long history, some crypto investors say.Bitcoinread more
The Fed is expected to cut rates multiple times, but the reason behind those cuts could have vastly different implications for the market.Marketsread more
"This is going to be the biggest thing that's happened to Facebook in years," says CNBC's Jim Cramer. "It will be vital."Investingread more
A recent Fed survey showed that workers' confidence for finding a new job after losing their current position was at 61.5% in May.Economyread more
These are the stocks posting the largest moves midday.Market Insiderread more
The red-hot market for new public companies in 2019 like Beyond Meat and Chewy could spell bad news for the stock market, Bernstein says.Marketsread more
The "captive carry flight test" evaluates the mock weapon during flight and is the Air Force's latest step amid the budding hypersonic arms race between China and Russia.Politicsread more
It's about time to write off high-growth tech stocks, Goldman warns, saying software carries the highest multiples since the tech bubble.Marketsread more
Profits for major U.S. tobacco companies could be cut in half if the FDA adopts a "maximum nicotine" rule within the next 15 years, according to analysts at Morgan Stanley.Tobaccoread more
Mursi, a top figure in the now-banned Muslim Brotherhood, had been in jail since being toppled by the military in 2013 after barely a year in power following mass protests...World Politicsread more
It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed:
Halliburton: "I don't want to recommend any oil stocks right now. I think that oil's going to $42 and all these stocks will be cheap. I've been telling that to the [ActionAlertsPlus.com] club members. I'm going to repeat that here."
Juno Therapeutics: "Look, that's one of the high-risk immunotherapy stocks. They're high-risk and they're high-reward. If you can handle that in some of your Mad Money portfolio, I bless it."
Merit Medical Systems: "This is a medical device company that I like. You know I like that group. I do think we should be a little more conservative. There's some more traditional ones like a Medtronic, but that's OK. I like Mazor [Robotics] and I also like Intuitive [Surgical]. There's a threefer. "
Bemis: "BMS is coming down. I think that people didn't like the quarter. I think it's a very great, long-term company. By the way, the symbol BMS is often thought of as being 'Buy My Stock.'"
Novartis: "Novartis is good. You don't want to sell Novartis. They're doing incredibly well. If anything, I'm interested in buying it if I can get it below $80."
Coupa Software: "We like Coupa Software. We think that they're doing terrific things, and I refer people to the archives. It was a great interview, I thought."
Sirius Radio: "I like Sirius. A lot of people are saying, 'Listen, that last quarter wasn't that good.' I didn't see it that way. I think it's fine. Buy half now, see if it goes under $5, and in what I think it is going to be an unfortunately negative sell-off, then buy the rest."
Chicago Bridge & Iron: "You know I haven't liked it for a long time, and even though it looks like it's so cheap down here at $9, down almost 70 percent, I'm sorry. I don't have a catalyst to turn this stock around."